compounding glp-1 news BREAKING in the space 🚨 , FDA is at it again saying they’re going to take action limiting access to the active ingredients used to make the compounded medications. , Watch this September 2, 2025: U.S. compounding

RCT study of moderate-quality indicated that L-carnitine did not influence serum lipid profiles except for reducing apolipoprotein B (ApoB)

The CagA protein increases iron uptake through TF endocytosis and decreases cytoplasmic labile iron pool while increasing lysosomal iron through enhanced expression of H-ferritin in H

This is exciting because while presently there are already 3 FDA approved medications for alcohol use disorder, their effects are modest

This helps prevent weight regain , a common concern after reaching weight loss goals

10.1155/2012/734125 75 MorrisG.AndersonG.DeanO.BerkM.GaleckiP.Martin-SuberoM.et al (2014)